Fortis Malar Hospitals (BOM:523696) ROCE %: 1.25% (As of Mar. 2026)


BOM:523696 Fortis Malar Hospitals Ltd BOM:523696
32 GF Score
Price ₹51.45
GF Value ₹0.03
Valuation Significantly Overvalued
View Full Analysis

What is Fortis Malar Hospitals ROCE %?

Fortis Malar Hospitals BOM:523696 -0.61% 32 ROCE % is 1.25% as of Mar. 2026. GuruFocus rates BOM:523696 with a GF Score™ of 32/100 and a GF Value™ of ₹0.03 (Significantly Overvalued).

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Fortis Malar Hospitals's annualized ROCE % for the quarter that ended in Mar. 2026 was 1.25%.

Fortis Malar Hospitals  (BOM:523696) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Fortis Malar Hospitals ROCE % Related Terms

Fortis Malar Hospitals ROCE % Historical Data

* Premium members only.

The historical data trend for Fortis Malar Hospitals's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fortis Malar Hospitals ROCE % Chart

Fortis Malar Hospitals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.24 -0.80 50.36 0.83 14.64

Fortis Malar Hospitals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.25 56.74 1.68 2.21 1.25
BOM:523696
32GF Score
Fortis Malar Hospitals Ltd BOM:523696
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fortis Malar Hospitals ROCE % Calculation

Fortis Malar Hospitals's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=47.26/( ( (368.32 - 66.229) + (376.034 - 32.569) )/ 2 )
=47.26/( (302.091+343.465)/ 2 )
=47.26/322.778
=14.64 %

Fortis Malar Hospitals's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=4.28/( ( (0 - 0) + (376.034 - 32.569) )/ 1 )
=4.28/( ( 0 + 343.465 )/ 1 )
=4.28/343.465
=1.25 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 1.25% mean?
Fortis Malar Hospitals (BOM:523696) has a ROCE % of 1.25% as of Mar. 2026.
Is Fortis Malar Hospitals' ROCE % too high?
Fortis Malar Hospitals' current ROCE % is 1.25%. The Healthcare Providers & Services industry median ROCE % is 6.41. Fortis Malar Hospitals' value of 1.25% is 80.5% below this industry median. Overall, Fortis Malar Hospitals has a GF Score™ of 32/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fortis Malar Hospitals' ROCE % compare to HCA and THC?
Fortis Malar Hospitals' ROCE % of 1.25% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. Fortis Malar Hospitals' value of 1.25% is 80.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 646 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fortis Malar Hospitals's current ROCE % of 1.25% is 80.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fortis Malar Hospitals's current ROCE % is 1.25%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fortis Malar Hospitals stock overvalued right now?
Based on GuruFocus' analysis, Fortis Malar Hospitals (BOM:523696) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹0.03, compared to a current price of ₹51.45 — trading 171400% above its estimated fair value. The current ROCE % is 1.25% and 80.5% below the Healthcare Providers & Services industry median of 6.41. Fortis Malar Hospitals' overall GF Score™ is 32/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Fortis Malar Hospitals (BOM:523696), the current ROCE % is 1.25% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fortis Malar Hospitals (BOM:523696) Overvalued in 2026?

Based on GuruFocus' analysis, Fortis Malar Hospitals stock appears to be overvalued. The current stock price of ₹51.45 is trading 171400% above its estimated GF Value™ of ₹0.03. GuruFocus considers Fortis Malar Hospitals to be Significantly Overvalued.

Key valuation signals for BOM:523696:

  • ROCE %: 1.25%
  • GF Value™: ₹0.03 vs. price of ₹51.45 (171400% above fair value)
  • GF Score™: 32/100
  • Industry Position: 80.5% below the Healthcare Providers & Services median

No single metric tells the full story. See the BOM:523696 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fortis Malar Hospitals Business Description

Address Fortis Hospital, Sector 62, Phase VIII, Mohali, PB, IND, 160062
Fortis Malar Hospitals Ltd is an India-based company engaged in the provision of healthcare services. It focuses on providing medical care in the areas of cardiology and cardiac surgery, neurosurgery, gynecology, orthopedics, gastroenterology, neurology, pediatrics, diabetes, nephrology, and internal medicine. The company provides healthcare services in various branches of medicine such as general surgery, general medicine, pediatrics, neurology, cardiology, ophthalmology, radiology, pathology, gastroenterology, urology, thoracic surgery, plastic surgery, and other allied specialties. It operates in one business, namely, in the health care services.
32GF Score

Get the complete analysis for BOM:523696

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹51.45
Price
₹0.03
GF Value